Hemodynamic Instability Following Carotid Artery Stenting
NCT ID: NCT01056445
Last Updated: 2010-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2008-05-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Blood Flow Changes and Microemboli During Carotid Surgery
NCT01343615
Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy
NCT03163459
Prediction of Hyperperfusion After Carotid Stenting by Multi-parameter Characteristics Based on Cerebral Autoregulation
NCT06058676
Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting
NCT01654666
Regional Hypothermia in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke
NCT04554797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and Methods: 27 patients were selected based on NASCET criteria and underwent CAS between September 2008 and September 2009. Continuous EKG monitoring \& supine blood pressure (BP) was obtained before and after stent deployment and on the following day to detect HI defined as systolic BP≤90mmHg or heart rate≤60 beats per minute. Patients were asked to perform Valsalva maneuver before and after stent deployment. Valsalva ratio along with other demographic and procedural data was documented and compared between patients with and without incidence of HI.
Results: 17 patients (63%) developed HI after CAS. The degree of stenosis was found to have a significant correlation with occurrence of HI with P value\<0.006. No other risk factor or demographic data showed any correlation with HI. Valsalva Ratio (VR) were significantly lower in HI group compared with non-HI group indicating a significant autonomic dysfunction (P\<0.003). In the follow-up one (4.3%) patient had developed major stroke and others were symptom free.
Conclusion: HI occurs frequently following CAS but seems to be a benign phenomenon and doesn't increase the risk of mortality or morbidity after the procedure in short-term. VR at rest (VR≤1.10) baseline autonomic dysfunction and degree of carotid artery stenosis can be used as measures for prediction of HI after CAS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
DIAGNOSTIC
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
carotid stenting and hemodynamic instability
27 patients undergone carotid stenting
valsalva maneuver
valsalva maneuver after carotid stenting
carotid stenting without hemodynamic instability
no hemodynamic instability after carotid stenting
valsalva maneuver
valsalva maneuver after carotid stenting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
valsalva maneuver
valsalva maneuver after carotid stenting
valsalva maneuver
valsalva maneuver after carotid stenting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* atrial fibrillation
* unstable patients with recent TIA and CVA in last week
* inability of patient to hold respiration for 30 seconds
* refusal of patient
49 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shiraz University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shiraz Univ ersity of medical Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
javad kojuri, M.D.
Role: PRINCIPAL_INVESTIGATOR
shiraz University of medical asciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shiraz University of Medical Sciences, Cardiovascular Research Center
Shiraz, Fars, Iran
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kojuri J, Ostovan MA, Zamiri N, Farshchizarabi S, Varavipoor B. Hemodynamic instability following carotid artery stenting. Neurosurg Focus. 2011 Jun;30(6):E12. doi: 10.3171/2010.12.FOCUS10219.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
88-1239
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.